EQT, Biontech investor family consider Sandoz bid

Investment group EQT and members of the Struengmann family, who are investors in Biontech , are considering a joint bid for Swiss pharmaceutical group Novartis's generics division Sandoz, German newspaper Handelsblatt reported on Friday, citing unnamed sources.